PRECIGEN, INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Precigen, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2012 to Q3 2024.
  • Precigen, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $12K.
  • Precigen, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$2.04M, a 1627% decline year-over-year.
  • Precigen, Inc. annual Income Tax Expense (Benefit) for 2023 was -$458K, a 142% decline from 2022.
  • Precigen, Inc. annual Income Tax Expense (Benefit) for 2022 was -$189K, a 18.1% decline from 2021.
  • Precigen, Inc. annual Income Tax Expense (Benefit) for 2021 was -$160K, a 95.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.04M $12K +$18K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$2.06M -$1.69M -$1.62M -2498% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$432K -$29K +$26K +47.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$458K -$332K -$340K -4250% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$118K -$6K +$44K +88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$162K -$65K +$24K +27% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$186K -$55K +$3K +5.17% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$189K $8K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$50K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$89K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$58K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2019 -$930K $685K -$3.43M -83.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $2.5M -$512K +$13.8M +96.4% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$11.3M -$525K +$602K +53.4% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 -$11.9M -$578K +$3.51M +85.9% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$15.4M $4.11M -$126K -2.98% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$15.3M -$14.3M -$13.5M -1651% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.8M -$1.13M -$314K -38.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$1.48M -$4.09M -$3.55M -667% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.07M $4.24M +$4.82M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$2.75M -$818K -$400K -95.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$2.35M -$813K -$222K -37.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$2.13M -$533K +$1.75M +76.6% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-08-13
Q4 2016 -$3.88M -$587K -$797K -380% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$3.08M -$418K +$505K +54.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$3.59M -$591K -$1.53M -163% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$2.06M -$2.28M -$3.08M -387% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.02M $210K +$336K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $680K -$923K -$923K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.6M $934K +$1.22M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $386K $795K +$489K +160% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$103K -$126K -$126K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $23K $0 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $23K -$283K -$283K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $306K $306K +$306K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $0 $0 Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $0 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $0 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-10-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.